Microneedling informed consent form template

· 4 min read

Editorial illustration about a microneedling informed consent form

Microneedling looks simple: a series of tiny punctures to stimulate the skin. But it breaks the skin barrier, and that carries real risks: infection, dark spots, herpes reactivation, and reactions to the active ingredients applied with it. The patient needs to know this, and the clinic needs a record.

This template is generic for facial microneedling. It includes no technique, depth or equipment brand. To understand the procedure, see microneedling and microneedling: fundamentals.

When should you use this template?

At the assessment, before the first session, together with the medical history. Update it if the protocol changes (number of sessions, area, active ingredients) or if there is new health information.

How do you adapt it?

Which risks and contraindications should you consider?

Topic What to record
Infection Broken skin is an entry point, hence the importance of asepsis and aftercare
Dark spots Risk of post-inflammatory hyperpigmentation, higher in some phototypes
Abnormal healing Tendency to keloids or hypertrophic scars
Herpes Possible reactivation
Active acne and lesions May be a temporary contraindication
Combined active ingredients Allergic reaction or irritation
Sun Exposure increases the risk of dark spots

The Fitzpatrick phototype helps in thinking about the risk of dark spots, but it does not replace individual assessment.

Microneedling informed consent form template

What happens when microneedling is combined with other procedures?

Combining it with injectables requires planning the interval and the risk. The patient needs to know this from the consent stage. For common questions, see microneedling after filler and microneedling and botox. Informed consent covers each procedure specifically.

Frequently asked questions

Does microneedling need its own consent form?

It is recommended. The procedure has its own risks and contraindications, such as infection, dark spots and herpes reactivation, and the patient should be aware of them. Confirm the requirements of your professional board.

Should the form mention the active ingredients used?

If substances are combined with it, yes: record which ones and that they can cause reactions. It is better to detail the composition and lot in the patient chart.

Does the form cover later sessions of the same protocol?

It usually covers the protocol described, as long as the plan does not change. If the goal, area or active ingredients change, record a new form or an addendum.

Terms mentioned